Certified by Founder Lodge 
                                        
                                        British Patient Capital
 
                                                 United Kingdom  -  Sheffield, England 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $80,000,000
                                            22 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Our mission is to enable long-term investment in innovative companies across the UK led by ambitious entrepreneurs.
The UK provides a fertile ground for innovation to thrive, but a lack of
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Quantexa | 
                                                            April, 04 ,2023 | Series E | $129,000,000 | 
   Proximie | 
                                                            August, 14 ,2022 | Series C | $80,000,000 | 
   Oxford Quantum Circuits | 
                                                            July, 05 ,2022 | Series A | $47,000,000 | 
   Curve Therapeutics | 
                                                            February, 28 ,2024 | Series A | $51,183,495 | 
   Quantum Motion | 
                                                            February, 22 ,2023 | Unknown | $50,500,000 | 
   Wagestream | 
                                                            April, 18 ,2024 | Unknown | $21,829,675 | 
   CyberSmart | 
                                                            February, 27 ,2023 | Series B | $15,386,000 | 
   Grey Wolf Therapeutics | 
                                                            May, 23 ,2024 | Series B | $50,000,000 | 
   Quantexa | 
                                                            April, 04 ,2023 | Series E | $129,000,000 | 
   Myricx Bio | 
                                                            July, 09 ,2024 | Series A | $115,246,800 | 
   Curve Therapeutics | 
                                                            February, 28 ,2024 | Series A | $51,183,495 | 
   Epsilogen Ltd | 
                                                            September, 10 ,2024 | Series B | $16,370,899 | 
   Wagestream | 
                                                            April, 18 ,2024 | Unknown | $21,829,675 | 
   Nuclera | 
                                                            October, 17 ,2024 | Unknown | $75,000,000 | 
   Grey Wolf Therapeutics | 
                                                            May, 23 ,2024 | Series B | $50,000,000 | 
   Tokamak Energy | 
                                                            November, 20 ,2024 | Unknown | $12,000,000 | 
   Myricx Bio | 
                                                            July, 09 ,2024 | Series A | $115,246,800 | 
   Cambridge GaN Devices Ltd | 
                                                            February, 19 ,2025 | Series C | $32,000,000 | 
   Epsilogen Ltd | 
                                                            September, 10 ,2024 | Series B | $16,370,899 | 
   Nuclera | 
                                                            October, 17 ,2024 | Unknown | $75,000,000 | 
   Tokamak Energy | 
                                                            November, 20 ,2024 | Unknown | $12,000,000 | 
   Cambridge GaN Devices Ltd | 
                                                            February, 19 ,2025 | Series C | $32,000,000 | 
                                                
  Quantexa
  Proximie
  Oxford Quantum Circuits
  Curve Therapeutics
  Quantum Motion
  Wagestream
  CyberSmart
  Grey Wolf Therapeutics
  Myricx Bio
  Epsilogen Ltd
  Nuclera
  Tokamak Energy
  Cambridge GaN Devices Ltd
Founderpath
 
                                            
Truework
Finix
Farther
TeamApt Inc.
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)